These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 5852646)

  • 1. [Studies on the stability of N,N-dimethyleneoxide-bis9pyridinium-4-aldoxime)-dichloride in aqueous solution].
    Bernasconi R
    Pharm Acta Helv; 1965 Oct; 40(10):564-74. PubMed ID: 5852646
    [No Abstract]   [Full Text] [Related]  

  • 2. Decomposition of a phosphonylated pyridinium aldoxime in aqueous solution.
    Steinberg GM; Solomon S
    Biochemistry; 1966 Oct; 5(10):3142-50. PubMed ID: 5971829
    [No Abstract]   [Full Text] [Related]  

  • 3. [Preparation of PAM-2C-1 and cholinolytics for parenteral administration and stability of oximes in aqueous solutions].
    Maksimović M; Vojvodić V
    Vojnosanit Pregl; 1972 Mar; 29(3):117-9. PubMed ID: 5030143
    [No Abstract]   [Full Text] [Related]  

  • 4. [PYRIDINE-2-ALDOXIME METHYLCHLORIDE (PAM-2 C1)].
    DIMKOVIC R; BINENFELD Z
    Vojnosanit Pregl; 1963 Dec; 20():758-9. PubMed ID: 14125761
    [No Abstract]   [Full Text] [Related]  

  • 5. Intermediates in the reduction of oximes in aqueous solutions.
    Neta P
    Radiat Res; 1976 Dec; 68(3):422-32. PubMed ID: 1005660
    [No Abstract]   [Full Text] [Related]  

  • 6. Quantum mechanical calculation of stability in 2-formyl N-methyl pyridinium (cation) oxime (2-PAM+) conformers.
    Giordano W; Hamann JR; Harkins JJ; Kaufman JJ
    Mol Pharmacol; 1967 Jul; 3(4):307-17. PubMed ID: 6033630
    [No Abstract]   [Full Text] [Related]  

  • 7. Determination of atropine in the presence of pralidoxime chloride.
    Lindén E; Schill G
    Acta Pharm Suec; 1967 Dec; 4(6):327-34. PubMed ID: 5589691
    [No Abstract]   [Full Text] [Related]  

  • 8. Synthesis of pyridine-2-aldoxime-C-14 methiodide (2-PAM-C-14 iodide).
    CLARK K; ROTH LJ
    J Pharm Sci; 1963 Jan; 52():96-7. PubMed ID: 14021526
    [No Abstract]   [Full Text] [Related]  

  • 9. Stability of pyridine-2-aldoxime methiodide. II. Kinetics of deterioration in dilute aqueous solutions.
    ELLIN RI; CARLESE JS; KONDRITZER AA
    J Pharm Sci; 1962 Feb; 51():141-6. PubMed ID: 13889913
    [No Abstract]   [Full Text] [Related]  

  • 10. [Determination of N-methyl-2-hydroxyimino-methyl pyridinium iodide (2-PAM) content in aqueous solutions].
    Cesk Farm; 1969 Oct; 18(8):417-8. PubMed ID: 5370688
    [No Abstract]   [Full Text] [Related]  

  • 11. In vitro oxime reactivation of red blood cell acetylcholinesterase inhibited by methyl-paraoxon.
    Petroianu GA; Arafat K; Nurulain SM; Kuca K; Kassa J
    J Appl Toxicol; 2007; 27(2):168-75. PubMed ID: 17265452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Behavior of N-alkyl-pyridinium-aldoximes in water-alkaline solution].
    Schoene K
    Arzneimittelforschung; 1968 Oct; 18(10):1350-1. PubMed ID: 5755718
    [No Abstract]   [Full Text] [Related]  

  • 13. Hydrolysis of bis(4-hydroxyiminomethyl-1-pyridiniomethyl)ether dichloride (Toxogonin). II. Kinetics and equilibrium in acidic solution.
    Christenson I
    Acta Pharm Suec; 1968 Sep; 5(4):249-62. PubMed ID: 5724367
    [No Abstract]   [Full Text] [Related]  

  • 14. [Pralidoxime methyliodate. Chimico-physical characteristics, chromatography, electrophoresis, lyophilization].
    Ruggieri R
    Boll Chim Farm; 1969 Oct; 108(10):611-8. PubMed ID: 5379182
    [No Abstract]   [Full Text] [Related]  

  • 15. Chromatographic separation of the degradation products of pralidoxime iodide (pyridine-2-aldoxime methiodide).
    ELLIN RI; EASTERDAY DE
    J Pharm Pharmacol; 1961 Jun; 13():370-3. PubMed ID: 13726417
    [No Abstract]   [Full Text] [Related]  

  • 16. Behavioral comparison of the oximes TMB-4, 2-PAM, and HI-6 in rats using operant conditioning.
    Genovese RF; Doctor BP
    Pharmacol Biochem Behav; 1997 Jan; 56(1):139-43. PubMed ID: 8981621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Determination of the structure of a fluorescent product of the alkaline hydrolysis of pralidoxime].
    Spoljarić G; Lozanović Z; Bonevski R
    Arh Hig Rada Toksikol; 1979 Dec; 30(4):333-43. PubMed ID: 533378
    [No Abstract]   [Full Text] [Related]  

  • 18. [Behavior of N-alkylpyridinium-aldoximes in aqueous alkaline solution. Supplement to the article].
    Schoene K
    Arzneimittelforschung; 1969 Feb; 19(2):242. PubMed ID: 5818766
    [No Abstract]   [Full Text] [Related]  

  • 19. Efficacy of two new asymmetric bispyridinium oximes (K-27 and K-48) in rats exposed to diisopropylfluorophosphate: comparison with pralidoxime, obidoxime, trimedoxime, methoxime, and HI-6.
    Lorke DE; Hasan MY; Nurulain SM; Kuca K; Schmitt A; Petroianu GA
    Toxicol Mech Methods; 2009 May; 19(4):327-33. PubMed ID: 19778224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Signs of cyclosarin-induced neurotoxicity and its pharmacological treatment with quaternary pyridinium-oximes reactivators.
    Krejcova-Kunesova G; Bartosova L; Kuca K
    Toxicology; 2005 Dec; 216(1):32-40. PubMed ID: 16126317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.